Clinical Trials Sponsored by Zhiwen Chen

Total 1599 results

Chen Xiaoping

Completed

VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy

Recurrence | HCC

China
Haiquan Chen

Completed

Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers

Lung Cancer

China
Chen Xiaoping

Completed

ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture

Peritoneal Metastasis

China
Chen Xiaoping

Completed

A Long-term Survival Analysis of Different Surgical Method in Early Hepatocellular Carcinoma

Long-term Effects of Cancer Treatment

China
TAO CHEN

Unknown

SIL-TEP vs TEP for Inguinal Hernia Repair in Day Surgery

Hernia, Inguinal

China
Chen Xiaoping

Not yet recruiting

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

HCC
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

Obesity | Atypical Endometrial Hyperplasia | Progesterone Resistance

China
Chen Xiaoping

Recruiting

Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma

HCC

China
Mengmeng Chen

Not yet recruiting

Ozone Autohemotherapy for Ischemic Stroke Sleep Disorder

Post-ischemic Stroke Insomnia
Chen Xiaoping

Completed

Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling

Hepatocellular Carcinoma | Checkpoint Inhibitor | Adjuvant Immunotherapy

China
Chen Xiaoping

Completed

Postoperative Adjuvant Therapy of HCC Based on PD-1

Hepatocellular Carcinoma | RFS

China
Chen Xiaoping

Unknown

Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma

China
Min Chen

Unknown

Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD)

Attention Deficit Hyperactivity Disorder

China
Rhizen Pharmaceuticals SA

Completed

Efficacy and Safety of Tenalisib (RP6530), a PI3K δ/γ and SIK3 Inhibitor, in Patients With Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Georgia
Rhizen Pharmaceuticals SA

Withdrawn

Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia
Rhizen Pharmaceuticals SA

Withdrawn

Study to Evaluate the Efficacy and Safety of Tenalisib, Given With CHOP Therapy for Front Line Treatment in Patients With PTCL

Peripheral T Cell Lymphoma

United States
Rhizen Pharmaceuticals SA

Completed

Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL)

Non Hodgkin Lymphoma

United States, Australia
Rhizen Pharmaceuticals SA

Terminated

Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals

Asthma | Healthy Volunteers

Canada
Rhizen Pharmaceuticals SA

Completed

Compassionate Use Study of Tenalisib (RP6530)

Hematological Malignancies

United States, Georgia, Poland
Rhizen Pharmaceuticals SA

Completed

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Solid Tumor | Metastatic Breast Cancer | Locally Advanced Breast Cancer | Extensive-stage Small-cell Lung Cancer | Platinum-Sensitive Fallopian Tube Carcinoma | Platinum-sensitive Ovarian Cancer | Platinum-Sensitive Peritoneal Cancer

Czechia, Poland
Rhizen Pharmaceuticals SA

Completed

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

T Cell Lymphoma

United States
Rhizen Pharmaceuticals SA

Completed

A Single and Multiple Ascending and Food Effect Study of RP7214, a DHODH Inhibitor in Healthy Adult Subjects

Healthy Volunteers

United States
Rhizen Pharmaceuticals SA

Completed

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral

United States
Rhizen Pharmaceuticals SA

Completed

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies (PI3K)

Lymphoma, B-Cell | T-Cell Lymphoma

France, Italy
Shih Chien University
Shin Kong Wu Ho-Su Memorial Hospital

Completed

Effects of Vitamin D Supplementation on Immune Function in Infants

Vitamin D Deficiency

Taiwan
Gang Chen (101199)

Not yet recruiting

A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer

Recurrent or Metastatic Cervical Cancer
Xiao Jie Chen

Not yet recruiting

Feeding Intolerance Risk Prediction Model in Patients With Enteral Nutrition Through Nasogastric Tube

Enteral Nutrition
Dunjin Chen

Not yet recruiting

Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRES

Cognitive Dysfunction | Neuroimaging | Posterior Reversible Encephalopathy Syndrome

China
Dunjin Chen

Not yet recruiting

Effects of Recurrent PE on Women and Offspring (RPOH)

Recurrence | Hypertension | Preeclampsia

China
Inna Chen, MD

Recruiting

BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC") (BIOPAC)

Pancreatic Cancer

Denmark
Dunjin Chen

Completed

Inflammatory Biomarkers for the Diagnosis of oPRES

Posterior Reversible Encephalopathy Syndrome | Inflammatory Biomarkers | Neutrophil-lymphocyte Ratio

China
Dunjin Chen

Completed

The Clinical and Prognostic Features of PRES

Eclampsia | Preeclampsia | Pregnancy Outcomes | Posterior Reversible Encephalopathy Syndrome

China
Chen Wannan

Unknown

Post Operative Pain Control of POEM Procedure

Achalasia
Li Chen

Unknown

Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media

Primary Hepatocellular Carcinoma

China
Inna Chen, MD

Recruiting

Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer (CheckVAC)

Pancreatic Cancer

Denmark
Hongli Chen

Not yet recruiting

Subjective Memory Complaints' Cognitive Intervention (SMCCI)

Subjective Memory Complaint
Chen Yueh

Recruiting

Functional and Electromyographical Changes After PRP or Dextrose Injection in Chronic Lateral Epicondylitis

Tennis Elbow

Taiwan
Jinglong Chen

Recruiting

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

Hepatocellular Carcinoma

China
Weikang Chen

Completed

A Retrospective Cohort Study of 15 Cases of Pelvic Fractures Complicated by Morel-Lavallee Lesion

Pelvic Fracture | Morel-Lavallee Lesion

China
Dunjin Chen

Completed

The Predictors of ICU Admission of oPRES

Intensive Care Units | Posterior Reversible Encephalopathy Syndrome

China
Wei Chen

Enrolling by invitation

Effect of Exercise on Indocyanine Green (ICG) Lymphography Imaging

Lymphedema

United States
Chen Yi Enterprise, Co., Ltd.

Completed

Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea

Dysmenorrhea

Taiwan
Chi-Ming Chu
Dr. Chiang, Shang-lin; Dr. Liang-Cheng Chen

Recruiting

Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index

Cardiac Output | Enhanced External Counterpulsation (EECP) | Cardiac Force Index

Taiwan
Rhizen Pharmaceuticals SA

Completed

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Leukemia, Lymphocytic, Chronic, B-Cell

Georgia, Bulgaria, Poland
Rhizen Pharmaceuticals SA

Terminated

Safety and Efficacy Study of Tenalisib (RP6530) in Combination With Pembrolizumab in Relapsed or Refractory cHL

Classical Hodgkin Lymphoma

United States
Rhizen Pharmaceuticals SA

Terminated

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

Lymphoma

United States, Australia
Rhizen Pharmaceuticals SA

Completed

To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers

Healthy

Canada
Jo Chien
Merck Sharp & Dohme LLC

Completed

Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer

Triple Negative Breast Cancer | Advanced or Metastatic Breast Cancer

United States
Chien Chih-Yin
National Taipei University of Nursing and Health Sciences

Enrolling by invitation

Efficacy of a Mindfulness-Based Intervention in Patients With Cardiovascular Implantable Electronic Device (MBI-CIED)

Depression | Anxiety | Resilience, Psychological | Perceived Stress | Mindfulness Training | Cardiac Resynchronization Therapy Devices

Taiwan
Wai-Tong Chien
Castle Peak Hospital

Completed

The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial (CHIP)

Schizophrenia | Schizoaffective Disorder | Bipolar Affective Disorder | Cardiovascular Health | Severe Mental Illness

Clinical Trials Sponsored by Zhiwen Chen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations